D01.49

Clinical Causes: Genetic mutations that affect cell growth and division Chronic inflammation of the intestinal lining (e.g., inflammatory bowel disease) Environmental factors such as diet, smoking, or exposure to carcinogens Certain hereditary conditions increasing the risk of gastrointestinal cancers Previous history of polyps or other precancerous lesions in the intestines

Key Symptoms: Typically asymptomatic in early stages Occasional abdominal discomfort or pain Changes in bowel habits, such as diarrhea or constipation Unexplained weight loss Occult bleeding which may cause anemia Fatigue and weakness in advanced cases

Diagnosis Path: Diagnosis of carcinoma in situ often involves a combination of procedures. Initial detection may occur through screening or investigation of symptoms, followed by: - Endoscopic procedures like colonoscopy or sigmoidoscopy, which allow direct visualization and biopsy of abnormal areas. - Histopathological examination of biopsy samples to confirm the presence of carcinoma in situ. - Imaging studies such as CT scans, MRI, or ultrasound to assess the extent of the lesion and rule out invasion or metastasis. - Laboratory tests including blood work to evaluate overall health and presence of anemia.

Treatment Protocols: Management of carcinoma in situ of the intestine typically involves: - Endoscopic removal of the lesion during colonoscopy if it is accessible and localized. - Surgical excision in cases where the lesion cannot be safely removed endoscopically or if there is suspicion of invasion. - Close surveillance and regular follow-up colonoscopies to monitor for recurrence or progression. - Lifestyle modifications aimed at reducing risk factors, such as dietary changes, smoking cessation, and management of inflammatory conditions. - Potential use of chemopreventive agents or medications under medical supervision in high-risk individuals.